Modulation of β-catenin signaling by glucagon receptor activation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Ke, Jiyuan ^a   Zhang, Chenghai ^a   Harikumar, Kaleeckal G ^c   Zylstra Diegel, Cassandra R ^a   Wang, Liren ^a   Mowry, Laura E ^a   Miller, Laurence J ^c   Williams, Bart O ^a   Xu, H Eric ^a,b  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DICKKOPF 1 PROTEIN; GLUCAGON; GLUCAGON RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; WNT PROTEIN; CATNB PROTEIN, MOUSE; CTNNB1 PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LRP5 PROTEIN, HUMAN; LRP5 PROTEIN, MOUSE; LRP6 PROTEIN, HUMAN; LRP6 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL STRAIN HEK293; CONTROLLED STUDY; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; LIVER CELL; MOUSE; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM;

ANIMALS; BETA CATENIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HEK293 CELLS; HEPATOCYTES; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MICE; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84863389953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033676     Document Type: Article

References (36)

1. Unson CG, (2002) Molecular determinants of glucagon receptor signaling. Biopolymers 66: 218-235.
2. Li XC, Zhuo JL, (2007) Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise. Clin Sci (Lond) 113: 183-193.
3. Wodarz A, Nusse R, (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88.
4. Huelsken J, Behrens J, (2002) The Wnt signalling pathway. J Cell Sci 115: 3977-3978.
5. He X, Semenov M, Tamai K, Zeng X, (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131: 1663-1677.
6. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
7. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
8. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, et al. (2003) Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 100: 4610-4615.
9. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS, (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310: 1504-1510.
10. Kulkarni NH, Halladay DL, Miles RR, Gilbert LM, Frolik CA, et al. (2005) Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 95: 1178-1190.
11. Suzuki A, Ozono K, Kubota T, Kondou H, Tachikawa K, et al. (2008) PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells. J Cell Biochem 104: 304-317.
12. Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, et al. (2006) Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147: 2583-2590.
13. Liu Z, Habener JF, (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283: 8723-8735.
14. Wan M, Yang C, Li J, Wu X, Yuan H, et al. (2008) Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev 22: 2968-2979.
15. Romero G, Sneddon WB, Yang Y, Wheeler D, Blair HC, et al. (2010) Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis. J Biol Chem 285: 14756-14763.
16. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 100: 229-234.
17. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278-1282.
18. Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, et al. (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116: 883-895.
19. Wan M, Li J, Herbst K, Zhang J, Yu B, et al. (2011) LRP6 mediates cAMP generation by G protein-coupled receptors through regulating the membrane targeting of Galpha(s). Sci Signal 4: ra15.
20. Burcelin R, Mrejen C, Decaux JF, De Mouzon SH, Girard J, et al. (1998) In vivo and in vitro regulation of hepatic glucagon receptor mRNA concentration by glucose metabolism. J Biol Chem 273: 8088-8093.
21. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
22. Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, et al. (2001) Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809.
23. Shevtsov SP, Haq S, Force T, (2006) Activation of beta-catenin signaling pathways by classical G-protein-coupled receptors: mechanisms and consequences in cycling and non-cycling cells. Cell Cycle 5: 2295-2300.
24. Barnes MR, Duckworth DM, Beeley LJ, (1998) Frizzled proteins constitute a novel family of G protein-coupled receptors, most closely related to the secretin family. Trends Pharmacol Sci 19: 399-400.
25. Cong F, Schweizer L, Varmus H, (2004) Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development 131: 5103-5115.
26. Umbhauer M, Djiane A, Goisset C, Penzo-Mendez A, Riou JF, et al. (2000) The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling. Embo J 19: 4944-4954.
27. Welters HJ, Kulkarni RN, (2008) Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol Metab 19: 349-355.
28. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
29. Holmen SL, Robertson SA, Zylstra CR, Williams BO, (2005) Wnt-independent activation of beta-catenin mediated by a Dkk1-Fz5 fusion protein. Biochem Biophys Res Commun 328: 533-539.
30. Holmen SL, Salic A, Zylstra CR, Kirschner MW, Williams BO, (2002) A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta-catenin-dependent signaling. J Biol Chem 277: 34727-34735.
31. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121-135.
32. Ke J, Chelvarajan RL, Sindhava V, Robertson DA, Lekakis L, et al. (2009) Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth. Mol Cancer 8: 132.
33. Harikumar KG, Pinon DI, Miller LJ, (2007) Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor. J Biol Chem 282: 30363-30372.
34. Cheng ZJ, Miller LJ, (2001) Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 276: 48040-48047.
35. Tusnady GE, Simon I, (2001) The HMMTOP transmembrane topology prediction server. Bioinformatics 17: 849-850.
36. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.